202020, re your:"if gsk is producing enough raw relenza powder for 240m doses/yr as has been confirmed this week..." Could you please let us know where this info came from and detail how it has been confirmed?
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint